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Probiotic treatment reduces 
appetite and glucose level  
in the zebrafish model
Silvia Falcinelli1, Ana Rodiles2, Suraj Unniappan3, Simona Picchietti4, Giorgia Gioacchini1, 
Daniel Lee Merrifield2 & Oliana Carnevali1
The gut microbiota regulates metabolic pathways that modulate the physiological state of hunger or 
satiety. Nutrients in the gut stimulate the release of several appetite modulators acting at central and 
peripheral levels to mediate appetite and glucose metabolism. After an eight-day exposure of zebrafish 
larvae to probiotic Lactobacillus rhamnosus, high-throughput sequence analysis evidenced the ability 
of the probiotic to modulate the microbial composition of the gastrointestinal tract. These changes 
were associated with a down-regulation and up-regulation of larval orexigenic and anorexigenic genes, 
respectively, an up-regulation of genes related to glucose level reduction and concomitantly reduced 
appetite and body glucose level. BODIPY-FL-pentanoic-acid staining revealed higher short chain fatty 
acids levels in the intestine of treated larvae. These results underline the capability of the probiotic 
to modulate the gut microbiota community and provides insight into how the probiotic interacts to 
regulate a novel gene network involved in glucose metabolism and appetite control, suggesting a 
possible role for L. rhamnosus in the treatment of impaired glucose tolerance and food intake disorders 
by gut microbiota manipulation.
The gut microbiota play an important role in influencing host metabolism, physiology and nutrition, lipid metab-
olism and growth performance1,2. Disruptions in the composition of gut microbial communities and altered inter-
actions between microbiota-host have been linked to several intestinal diseases, including cancer and metabolic 
disorders3,4. Research has focused on treatments to manipulate and restore the diversity of the gut microbiota and 
it have been observed that probiotics modulate the microbial composition, and can also modify host nutrient 
metabolism and energy homeostasis5. The mechanisms by which the microbiota influence host metabolism are 
partly described.
A recent study on Non-Obese Diabetic (NOD) mice showed that changes to the gut microbiota community 
and metabolism which contributes to changes in the host glucose metabolism and leads to the pathogenesis of 
type 1 diabetes6. Using the Drosophila melanogaster model, it has been demonstrated that host genotype and 
microbiota are stricly correlated, with the microbiota regulating host signaling and regulatory networks7, including 
the regulation of triglycerides and glucose metabolism8. Using the zebrafish model, we have demonstrated that 
manipulation of the gut microbiota with probiotics can regulate host lipid metabolism through down-regulation 
of genes involved in cholesterol and triglycerides metabolism (fit2, agpat4, dgat2, mgll, hnf4a, scap, and cck)2. In 
contrast, the effect of probiotics on host glucose metabolism and appetite remains largely unkown.
In both mammalian and teleost species, appetite and glucose metabolism are controlled by complex metabolic 
pathways through the production of several major hormones9. The hypothalamic circuit has a crucial role in reg-
ulating appetite control and glucose metabolism, but peripheral organs are also responsible for the production of 
circulating factors that influence appetite control and glucose metabolism10,11.
A wide network of molecules regulate appetite control and among these, the hormone leptin is responsible for 
regulating food intake and energy expenditure12. Leptin was first discovered in mice and is a 16 kDa circulating 
hormone produced by the obese (ob) gene13. Leptin is mainly produced by adipose tissue; its receptors are located 
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in the central nervous system and other tissues, such as the brain, stomach, placenta and pituitary gland14,15. Several 
studies have demonstrated that mutations in the ob gene cause leptin deficiency and leads to obesity16. Different 
studies, both in mammal and fish, reveal that leptin is able to reduce food intake by up-regulating anorexigenic 
signals, such as melanocortin-4-receptor (MC4R), and down-regulating orexigenic signals, such as neuropeptide 
Y (NPY) and cannabinoid receptor 1 (CB1)17,18. MC4R is expressed in the hypothalamic nuclei19 and a recent 
study in mice revealed that knock-out of MC4R directly induces lipid uptake and triglyceride synthesis promoting 
obesity20, meanwhile studies in humans and mice demonstrate that the activation of MC4R limits the accumulation 
of body fat by reducing food intake21.
Conversely, CB1 is mainly expressed in the brain and is responsible for food intake and weight gain22. It has 
been demonstrated that CB1 receptor increases hepatic lipid accumulation through the stimulation of the lipogenic 
transcription factor SREBP-1c and increases de novo fatty acid synthesis23. Like CB1, NPY and its Y receptors also 
stimulate food intake24. In the rat model, NPY has acute effects on glucose metabolism by increasing glucagon, 
insulin, and corticosterone25; moreover, a recent study demonstrated the role of NPY in stimulating lipid accu-
mulation through pre-adipocyte proliferation, suggesting an important emergent role of NPY on adipogenesis26.
Previously, Oh-I27 and collaborators discovered an anorexigenic hormone named nesfatin-1 (nucleobin-
din2 (NUCB2)-encoded satiety- and fat-influencing protein) which is an 82-amino-acid peptide encoded in 
the N-terminal region of the precursor peptide nucleobindin 2 (NUCB2). The 396-amino-acid precursor pro-
tein NUCB2 is highly conserved among rodents and humans as well as non-mammalian vertebrate species28,29. 
NUCB2/Nesfatin-1 has a negative role in appetite control and inhibits NPY transcription and enhances insulin 
release from β -cells27,30. Among the circulating factors produced by peripheral organs, glucagon-like peptide-1 
(GLP-1), a gut hormone secreted by L-cells, stimulates insulin secretions and inhibits glucagon release, promotes 
satiety, reduces food intake and slows gastric emptying9,31. In addition, the pancreatic endocrine tissues play a key 
role in the regulation of glucose metabolism through the production of several fundamental hormones such as 
insulin, somatostatin and glucagon, which are directly secreted into the blood32,33. When glucose is introduced 
with the diet, β -cells of the pancreas produce insulin to decrease the sugar level in the bloodstream, however, when 
there is a lack of glucose in the bloodstream, pancreatic α -cells produce glucagon which induces gluconeogene-
sis9,33. Moreover, ghrelin O-acyl transferase (GOAT) is highly conserved from humans to zebrafish34 and has been 
identified as the enzyme responsible for the unique n-acyl modification of ghrelin, a multifunctional orexigenic 
gut hormone31,34. GOAT is linked with glucose metabolism and its lack of transcription leads to increased insulin 
secretion and reduced body weight35.
The objective of the present study was to assess the effect of probiotic Lactobacillus rhamnosus supplementation 
on appetite and glucose metabolism by using Danio rerio larvae as a model. In order to achieve this, we assessed the 
zebrafish gastrointestinal (GI) microbiota after exposure to the probiotic, as well as the transcriptional regulation 
of genes involved in appetite control and glucose metabolism, whole organism glucose levels, and feed intake.
Results
L. rhamnosus modulates the GI microbiome. High-throughput sequence analysis of bacterial 16S 
rRNA V1-V2 regions at 8 days post fertilization (dpf) revealed a highly diverse microbiota with a total of 348 
thousand unique reads (with an average length of 293 ± 66 bp), representing 186 OTUs, from over 1.24 million 
raw reads. Using USEARCH default parameters, a de novo UCHIME algorithm36 was used to identify poten-
tial chimeric sequences, which accounted for 2.5% of the total sequences. Alpha rarefaction plots of observed 
species reached a saturation phase at approximately 147 OTUs indicating that adequate sequence coverage was 
obtained to reliably describe the full diversity present in the samples (Fig. 1A). This was verified by the Good’s 
coverage estimation values of > 99.9%, although the control group reached significantly higher coverage (0.9997 
vs 0.9994) (Table 1). The Shannon´s diversity parameter demonstrated a significantly lower microbial diversity in 
the probiotic group (2.96 ± 0.59) compared to control group (4.16 ± 0.11) (P < 0.05) (Table 1). In order to eval-
uate relationships among samples based on differences in phylogenetic diversity, a dendrogram and two-dimen-
sional principal coordinate analysis (PCoA) plot were constructed for the estimation of the dissimilarity among 
samples37 (Fig. 1E) and for the evaluation of the community composition, from weighted UniFrac distances38 
(Fig. 1F). Both plots show clustering of the replicates from the probiotic treatment away from the control repli-
cates, and they presented significant differences in Moran’s index, as well as the ANOSIM of Bray-Curtis simi-
larity (P < 0.05), suggesting that the probiotic modified the bacterial communities in a characteristic direction.
In general, the distinguishable separation of bacterial communities found in PCoA was accompanied with 
significant differences in the phylogenetic composition of the gut microbiota. The bacterial communities in both 
treatments were dominated by two phyla: Proteobacteria and Firmicutes (Fig. 1B), however, the control group 
consisted of a significantly higher relative abundance of sequences belonging to the Proteobacteria (84.9%) than 
the probiotic group (34.8%) (P = 0.011), and the probiotic group showed higher relative abundance of Firmicutes 
(62.6%) sequences than the control group (12.9%) (P = 0.013). The relative abundance of Actinobacteria was 
significantly lower (P = 0.011) in the probiotic group (0.2%) than the control (1.1%). A small proportion of the 
reads were identified as belonging to the Cyanobacteria (0.3% in the control and 0.1% in the probiotic treatment) 
and Fusobacteria (0.8% in the control and 2.3% in the probiotic treatment) phyla. Taking into account the relative 
abundance of OTUs accounting for greater than 0.5% of the reads, 92% of the reads were resolved to order-level, 
88% at family-level and 63% at genus-level (Fig. 1C). Firmicutes were dominated by the family Lactobacillaceae 
which was significantly higher in the treated group (P = 0.019). In the control group, Proteobacteria was dom-
inated by the Families Rhodospirillaceae, Hyphomicrobiaceae, Methylobacteriaceae and Mycobacteriaceae, all 
of which were significantly more abundant in the control group than the probiotic (P < 0.05). Reads assigned to 
the Lactobacillus genus were significantly higher in the probiotic treated larvae (accounting for 55.2% of the total 
reads) than the control larvae (accounting for 11.5% of the reads) (P = 0.019); BLAST results confirmed that the 
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Figure 1. Gastrointestinal bacterial community analysis of 8 dpf zebrafish larvae. (A) Alpha rarefaction 
plot of observed species. Relative abundance of reads at the phylum (B) and genera (C) level (taxa accounting 
for > 0.5% are represented). (D) Venn diagram showing the distribution of OTUs (those with > 0.01% relative 
abundance are represented) revealing a shared community consisting of 43 OTUs. Cluster using Bray-Curtis 
metrics (E) and 2D Principal coordinate analysis (PCoA) plot of weighted UniFrac distances (F). *P < 0.05.
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lactobacilli in the probiotic samples were L. rhamnosus (NR-102778). Although numerically different (7.0% in 
the probiotic vs 0.2% in the control) the abundance of reads assigned to the Streptococcaceae family did not differ 
significantly between treatments; BLAST revealed that this genus was comprised solely by Streptococcus thermo-
philus (NR- 074827). A core microbiome, detected in both treatment groups, was identified and comprised of 43 
genera (Fig. 1D); these were Acinetobacter, Acidovorax, Agrobacterium, Bacillus, Cetobacterium, Corynebacterium, 
Delftia, Devosia, Hydrogenophaga, Lactobacillus, Legionella, Leuconostoc, Mycobacterium, Mycoplana, Nevskia, 
Paracoccus, Phenylobacterium, Plesiomonas, Pseudomonas, Pseudoxanthomonas, Propionibacterium, Rhodoplanes, 
Sphingopyxis, Staphylococcus, Streptococcus genera and 18 additional genera which could not be accurately iden-
tified. Nine genera were unique to the fish treated with the probiotic (Comamonas, Vibrio, Mesorhizobium, 
Sphingobium, Rubrivivax, Prosthecobacter, one unidentified genera from the Family Pseudomonadaceae and two 
unidentified genera from the Orders Sphingomonadales and 34P16).Twenty genera were uniquely detected in the 
control fish (Acidaminococcus, Enhydrobacter, Enterococcus, Cupriavidus, Finegoldia, Flectobacillus, Kaistobacter, 
Methylibium, Pediococcus, Peptoniphilus, Polynucleobacter, Trabulsiella, Weissella and seven unidentified genera) 
(Fig. 1D). Additionally, a higher proportion of reads were assigned to the Mycobacterium genus in the control 
group (P = 0.026) (Fig. 1C).
Probiotic treatment modulates the expression of genes involved in glucose metabolism and 
reduces the total glucose levels in zebrafish larvae. Since after the probiotic supplementation the 
zebrafish larvae showed modulated GI microbiota communities we wanted investigate the effects of the changes 
on the expression of genes involved in glucose metabolic pathways by performing Real Time PCR and glucose 
level analysis. Nucb2a, glp-1 and insulin gene products play crucial roles in glucose metabolism through the 
regulation of glucose levels in the blood9,27. In particular, nucb2a and Glp-1 act by up-regulating insulin release, 
the product of which decreases the sugar level in the bloodstream30,33. The results obtained by Real Time PCR 
revealed that the probiotic administration was able to significantly increase the transcript levels of nucb2a at all 
developmental stages (Fig. 2A) and Glp-1 (Fig. 2B) and insulin at 6 dpf and 8 dpf (Fig. 2C). GOAT plays the oppo-
site role in glucose metabolism. Energy balance directly affects goat mRNA expression with a down-regulation 
taking place in times of energy abundance which leads to an increase of insulin secretion34,39. The microbiota 
changes induced by probiotic treatment reduced the expression of goat at 96 hpf and 6 dpf compared to the con-
trol (Fig. 2D). Since the probiotic supplementation down-regulated the expression of genes that decrease glucose 
levels in the blood, we wanted to gain further information by measuring the glucose levels of 8 dpf whole-larva 
using an enzymatic assay that detects free glucose. Interestingly, the results obtained showed a significantly lower 
glucose level in larvae treated with probiotic (1.61 ± 0.36 μ gμ L−1) than the control larvae (4.30 ± 1.48 μ gμ L−1) 
(P = 0.04) (Fig. 2E).
Probiotic treatment modulates the expression of genes involved in appetite control and 
decreases appetite in zebrafish larvae. Given that the modulation of microbiota community in the 
zebrafish GI after probiotic supplementation modulated transcripts involved in glucose metabolic pathways we 
wanted to further investigate the effects of the microbiota changes on the expression of genes related with the 
appetite by performing Real Time PCR and feed intake analyses.
Leptin and mc4r gene products are responsible for reducing food intake15,40. Our data show that the transcrip-
tional levels of leptin and mc4r were significantly increased by the probiotic treatment. Leptin expression was 
significantly increased in the treated group in all of the developmental stages analyzed (96 hpf, 6 dpf and 8 dpf) 
(Fig. 3A), whereas mc4r expression was significantly higher only at 96 hpf (Fig. 3B).
On the contrary, cb1 and npy are responsible for enhancing appetite stimulus41,42. The probiotic treatment sig-
nificantly decreased the expression levels of cb1 and npy transcripts, showing the same trend of expression for both 
genes. Compared to the control, probiotic treatment significantly down-regulated the expression of cb1 at 96 hpf and 
8 dpf, (Fig. 3C) and npy gene expression was significantly lower in all the developmental stages analyzed (Fig. 3D).
Since we reported a decrease of expression of orexigenic genes and an increase of anorexigenic genes, we wanted 
to elucidate the effect of the supplementation of probiotic L. rhamnosus on zebrafish appetite by measuring feed 
intake. At 8 dpf zebrafish larvae were fed newly-hatched Artemia salina nauplii and the results demonstrated a 
significant reduction of feed intake (8.00 ± 2.91 A. salina nauplii per larvae) in the probiotic treated larvae with 
respect to the control (17.00 ± 2.99 A. salina nauplii per larvae) (P = 0.0005) (Fig. 3E).
Ultrastructural analysis of zebrafish gut exposed to L. rhamnosus evidenced an increase of 
absorptive surface area. The proximal intestines of both control and treated larvae showed an undamaged 
epithelial barrier, no signs of degradation and an absence of cell debris in the lumen at 8 dpf (Fig. 4). The entero-
cytes lengths in the intestine of the probiotic treated larvae were significantly higher (42.54 ± 1.48 μ m) compared 
to those of the control group (34.92 ± 2.34 μ m) (P = 0.0001). In addition, we found significantly longer microvilli 
Observed species Chao1 Shannon Phylogenetic diversity Good’s coverage
Control 164.25 ± 7.69 174.14 ± 6.37 4.68 ± 0.21b 4.52 ± 0.15 0.9997 ± 0.0000b
Probiotic 155.09 ± 5.81 167.23 ± 3.52 3.23 ± 0.65a 4.30 ± 0.22 0.9995 ± 0.0001a
Table 1. Alpha diversity metrics of observed species, Chao1, Shannon’s diversity, phylogenetic diversity 
and Good’s coverage of zebrafish larvae of 8 dpf (mean ± s.d.; n = 3). Values with different superscripts, 
within the same row, are significantly different at P < 0.05.
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in the intestine of L. rhamnosus exposed larvae (1.02 ± 0.08 μ m) compared to the control larvae (0.91 ± 0.07 μ m) 
(P  = 0.008). Finally, TEM micrographs showed the presence of lipid droplets located in the basal enterocytes 
cytoplasm of both control and treated group. Probiotic treated larvae displayed significant smaller lipid drop-
lets diameters (2.29 ± 0.37) compared to those present in the intestine epithelium of control group (3.54 ± 0.61) 
(P = 0.0001). (Table 2).
 In vivo short chain fatty acids localization revealed accumulation in the intestine and gallblad-
der of probiotic treated zebrafish. Fermentation of carbohydrates by the gut microbiota results in the 
production of short-chain fatty acids (SCFAs), principally propionic, acetic and butyric acids which stimulate 
the growth of colonic epithelial cells and confers protection to the host against infection by pathogens43,44. Since 
we evidenced an expansion of intestine epithelium structure (i.e. microvilli and enterocytes height) and changes 
in the gut microbiota composition, possibly stimulated by the presence of SCFAs as final products of microbiota 
Figure 2. Probiotic treatment modulates the expression of genes involved in glucose metabolism and 
reduces the whole organism glucose levels in zebrafish larvae. Relative nucb2a (A), Glp-1 (B), insulin (C), 
goat (D) gene expression normalized against β-act and rplp, in pools of 15 zebrafish larvae from control and 
probiotic groups collected at hatching, 96 hpf, 6 dpf and 8 dpf. Assays were performed in triplicate. (E) Total 
larvae glucose levels, determined from 4 pools of larvae per treatment at 8 dpf, were significantly reduced by 
probiotic treatment. Value with different letters and asterisk is significantly different (P < 0.05).
www.nature.com/scientificreports/
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activity, we wanted to determine whether the microbiota changes modulated the SCFAs content in the larval gut. 
We used BODIPY C5 (borondipyrromethene fluorescent moiety) as non-invasive in vivo method in order to vis-
ualize SCFA (C-5) dynamics in living tissues by fluorescence microscopy. Images showed no signs of degradation 
in both bodies of control (Fig. 5A) and treated larvae (Fig. 5C) after being soaked in the BODIPY C5. In addition, 
images obtained by fluorescence microscopy revealed significantly higher fluorescent signals in the probiotic 
treated gut and gallbladder (Fig. 5D) (539.7 ± 49.7 a.u., Fig. 5E) and intestine (Fig. 5D) (405.0 ± 26.0 a.u., Fig. 5F) 
with respect to the control gallbladder (Fig. 5B) (348.3 ± 45.0 a.u., Fig. 5E) and intestine (Fig. 5B), (315.3 ± 24.1 
a.u., Fig. 5F) and suggesting an accumulation of SCFAs (P = 0.04).
Figure 3. Probiotic treatment modulates the expression of genes involved in appetite control and decreases 
appetite in zebrafish larvae. Relative leptin (A), mc4r (B), cb1 (C), npy (D) gene expression normalized against 
β-act and rplp, in pools of 15 zebrafish larvae from control and probiotic groups collected at hatching, 96 hpf, 
6 dpf and 8 dpf. (E) Control and probiotic treated zebrafish larvae were fed at 8 dpf with newly-hatched Artemia 
salina nauplii. The probiotic group show significant reduction of feed intake with respect to the control. Value 
with different letter and asterisk is significantly different (P < 0.05).
www.nature.com/scientificreports/
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Discussion
In the present study we observed changes of zebrafish gut microbiota composition induced by L. rhamnosus 
administration. The resultant microbiome decreased appetite and glucose by regulating the transcription of genes 
involved in the control of feed intake and glucose metabolism.
As already demonstrated in previous studies in our lab, L. rhamnosus was able to populate the zebrafish GI tract 
and induce changes to the microbial composition2,45. Probiotic administration resulted in a significant increase in 
Figure 4. Transmission Electron Microscopy (TEM) shows the ultrastructure of the intestinal in control 
and probiotic treated zebrafish. Thin sections of 8 dpf zebrafish showing columnar epithelia with apical brush 
border in control (A) and probiotic treated intestine (B). The treated intestines present abundant spherical 
mitochondria located in the apical part of the enterocytes, close to the brush border. Both control and treated 
group larvae intestine show undamaged epithelial barrier and absence of cell debris. Electron micrographs 
show organized microvilli on the apical surface in the enterocyte of control (C) and treated larvae (D) and the 
presence of lipid droplets in the enterocytes cytoplasm of control (E) and treated larvae (F). BB: brush border; L: 
lumen; M: mitochondria; m: microvilli, arrow: lipid droplets; *nucleus. Scale bar: 10 μ m in (A); 5 μ m in  
(B, E, F); 1 μ m in (C,D).
www.nature.com/scientificreports/
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the proportion of reads assigned to the Firmicutes and a decrease in reads assigned to the Proteobacteria, compared 
to the control larvae. This was primarily caused by a significant elevation of abundance in reads assigned to the 
Lactobacillus genus (namely L. rhamnosus) and a substantial increase in reads assigned to the Streptococcus genera 
(namely S. thermophilus). This supports the observations previously demonstrated by our lab and suggests that 
the application of this probiotic consistently enhances the presence of S. thermophilus in multiple experiments at 
multiple zebrafish life stages (6 months old,45; 6 dpf,2; 8 dpf, this study). Elevations in the presence of these organ-
isms coincided with relative reductions in the abundance of a number of genera, such as Mycobacterium, which 
include pathogenic species, as was previously reported in 6 dpf zebrafish larvae treated with this probiotic2. The 
significant reductions in number of species led to a reduction in the diversity of the microbiota present in the GI 
tract of the probiotic treated larvae.
The supplementation of L. rhamnosus, and the associated microbial changes in the GI tract, modulated the 
expression of a complex network of genes involved in appetite control and glucose metabolism. Leptin has a key 
role in the regulation of energy homeostasis and appetite in both fish and mammals15,46. Several studies highlighted 
that leptin, through the up-regulation of mc4r and the down-regulation of npy and cb1, is able to reduce food 
intake17,18,41. Our results evidenced that the expression of the leptin gene was increased by microbiota changes 
related with L. rhamnosus treatment. The up-regulation of leptin reflected the increase of expression of anorexi-
genic (mc4r) and a decrease of orexigenic (npy and cb1) signals in treated larvae. These results suggest a potential 
role of the probiotic modified microbiota to modulate these interconnected genes involved in the regulation of 
appetite, which was supported by the decrease of food (i.e. Artemia salina nauplii) intake in the probiotic treated 
zebrafish larvae.
The changed microbiota also affected glucose metabolism; NUCB2a/Nesfatin-1 gene expression was significantly 
up-regulated by the probiotic treatment, concomitantly with a significant increase of the expression of insulin gene. 
A number of studies have evidenced that NUCB2a/Nesftain-1, an emerging anorexigenic hormone, has a significant 
role in appetite control and glucose metabolism since it is able to increase insulin release from β -cells27,30,47. In 
addition, we observed that the increase of insulin gene expression in probiotic treated fish reflected a decrease of 
goat transcripts in the probiotic treated larvae. GOAT has emerged as molecule of interest since has been recently 
identified as the enzyme responsible for the activation of ghrelin, a multifunctional metabolic hormone which 
stimulates food intake and, moreover, maintains glucose homeostasis39. Studies on mice have demonstrated that 
the administration of GO-CoA-Tat, a bisubstrate analogue that operates as a GOAT inhibitor, caused a significant 
increase of insulin secretion in pancreatic β cells, and in addition, a study showed that GOAT knockout mice gained 
significantly less weight and had reduced fat mass when fed on a high-fat diet35,48,49.
These data evidenced the novel effect of the probiotic modified microbiota to acts at a transcriptional level and 
up-regulated the expression of genes which reduce glucose levels and concomitantly significantly reduced the 
glucose level in the treated larvae.
In addition, the metabolic activity of lactic acid bacteria, such as L. rhamnosus and S. thermophilus, can pro-
duce several types of SCFAs such as acetic, butyric, propionic acid and lactic acid as the end products of carbo-
hydrate fermentation43,50. Interestingly, BODIPY C5 accumulation in the intestine and gallbladder of probiotic 
treated larvae indicates that this fatty acid analogue stain is absorbed by the intestine and binds FAs51,52. The 
enhancement of the fluorescence in the intestine of probiotic treated larvae is likely due to elevated production 
of SCFAs, which is indicative of increased abundance and/or activity of fermentative bacterial species. Recent 
studies evidenced that the SCFA butyrate enhanced the release of the peptide GLP-1, which is involved in the 
regulation of appetite and food intake and glucose metabolism through the up-regulation of insulin gene expres-
sion from intestinal L-cells53,54. Interestingly, our data show an up-regulation of glp-1 gene expression level in the 
larvae treated with probiotic, which could be due to the production of SFCA as results of the metabolic activity 
of lactic acid bacteria.
We also observed that the administration of probiotic affected the architecture of the zebrafish intestine. The 
enterocytes in the posterior intestines of the probiotic treated larvae contained smaller lipid droplets than the 
control larvae. This may be due to decreases of fat storage-inducing transmembrane proteins 2 (FIT-2) transcripts 
as we observed in our previous work2 since FIT2 is implicated in the formation of lipid droplets55. Microvilli and 
enterocytes heights increased with probiotic treatment, and the improvements registered here at 8 dpf were greater 
than those we reported previously at 6 dpf 2. The epithelial architecture is directly correlated with the gut function 
and health of the host; in fact, increasing microvilli and enterocyte heights provides increased absorptive surface 
area. Semova and collaborators56 identified that the colonization of the zebrafish gut by Firmicutes promotes 
epithelial absorption, by modulating the energy balance of zebrafish larvae. Since, SCFAs derived from gut micro-
biota fermentation activities stimulate the growth of intestinal epithelial cells, we speculate that the expansion of 
microvilli and enterocytes in the gut of probiotic treated larvae may be due to the increased presence of SFCAs in 
tandem with the elevated abundance of Firmicutes43.
Control Probiotic P value
Enterocytes length 34.92 ± 2.34 μ m 42.54 ± 1.48 μ m 0.0001
Microvilli length 0.91 ± 0.07 μ m 1.02 ± 0.08 μ m 0.008
Lipid droplets diameter 4.75 ± 1.12 μ m 2.02 ± 0.72 μ m 0.0001
Table 2.  Probiotic treatment enhances enterocytes and microvilli length and reduce lipid droplets size. 
Enterocytes, microvilli and lipid droplets diameter were measured in 8 dpf zebrafish larvae from control and 
treated group at 8 dpf. 
www.nature.com/scientificreports/
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The findings we report provide novel insights on the role exerted by a L. rhamnosus induced modulated GI 
microbiome on host appetite and glucose metabolism, highlighting the hypoglicemic properties achieved by 
inducing transcriptional changes of a novel gene network.
The zebrafish is one of the most widely used animal models for developmental research and it is now gaining 
popularity and becoming an attractive model for toxicological screening and drug discovery, as well as for the study 
of metabolic disorders. Therefore, the results discussed here suggest a suitable potential use for L. rhamnosus for 
improving glucidic profile in impaired glucose tolerance diseases and to reduce appetite in food intake disorders.
Figure 5. BODIPY C5 staining shows an accumulation of short chain fatty acids (SCFA) in the intestine 
and gallbladder of probiotic treated larvae. Representative fluorescent images of live 8 dpf zebrafish immersed 
in BODIPY C5 for 1 hour. Images revealed a remarkable presence of SCFA in probiotic treated larvae (B–D) 
that exhibited higher fluorescent signal in the intestine and gallbladder compared to the control one (A–C). Red 
asterisk: gallbladder; I: intestine. Scale bar: 500 μ m. Probiotic treated larvae display significantly enhancement 
of fluorescent signal in the gallbladder (E) and in the intestine (F) with respect to the control group, highlighting 
an accumulation of short chain fatty acids (SCFA). Quantification of fluorescence is expressed in a.u. The data 
are reported as mean ± s.d from 3 individual experiments. The significance of differences between groups for 
these values was determined using Student’s t-test. Data are the mean ± s.d. Asterisks indicates significant 
differences (P < 0.05).
www.nature.com/scientificreports/
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Material and Methods
Animals and probiotic administration. Adult female and male zebrafish (D. rerio) were purchased 
from Acquario di Bologna (Italy) and acclimatized to the laboratory conditions (27.0 ± 0.5 °C under a 12:12 h 
light:dark photoperiod). Pairs were spawned individually and larvae were raised under a 12:12 h light:dark cycle 
at 27 °C. Embryos were collected and after hatching were divided into a control group and a probiotic-treated 
group. Larvae were fed a commercial diet (JBL flakes, Germany) consisting of 43.0% crude protein, 8.3% crude 
fat, 8.1% ash, 1.9% fibre and 8.0% moisture content. The probiotic treatment consisted of the administration of 
L. rhamnosus IMC 501® (C025396A; Synbiotec, Camerino, Italy) via the rearing water at a concentration of 106 
colony-forming units (CFU) ml−1 according to previous studies2. The experiment was set up in triplicates, with 
three control tanks and three probiotic tanks and from each tank a pool of larvae was collected at each time point. 
The experiment was repeated three times.
At hatching, 96 hpf, 6 dpf and 8 dpf, larvae were anesthetized using MS222 (100 mg L−1) (Sigma-Aldrich, Milano, 
Italy) and samples were collected and stored at − 80 °C for Real time PCR analyses. Since at 8 dpf, molecular anal-
ysis revealed significant changes of expression of most of the genes analyzed, high through-put sequence analysis, 
measurement of glucose level, feed intake, Transmission Electron Microscopy (TEM) and BODIPY staining were 
performed at this stage of development.
All the procedures involving animals were conducted in accordance with the Italian law on animal experi-
mentation and were approved by the Ethics Committee of Università Politecnica delle Marche (Prot #63/INT/
CESA12-16). All efforts were made to minimize suffering and a humane endpoint was applied with an excess of 
anesthetic (MS222, Sigma- Aldrich, Milano, Italy) when animals reached a moribund state.
DNA extraction and PCR. Larvae from 8 dpf were surface sterilized with 0.1% NaOCl for 30 s and then 
washed 3 times with Tris-EDTA buffer. DNA was extracted following57
PCR amplification of the 16S rRNA V1-V2 regions was conducted as described by58. One μ L of DNA template 
was used in the PCR reactions. The PCRs was performed in a TC-512 thermal cycler (Techne, Staffordshire, UK) 
under the following conditions: initial denaturation at 94 °C for 7 min, then 10 cycles at 94 °C for 30 s, followed by 
a touchdown of 1 °C per cycle from 62 − 53 °C for 30 s and 72 °C for 30 s. A further 20 cycles were performed at 
94 °C for 30 s, 53 °C for 30 s, 72 °C for 30 s and a final extension 72 °C for 7 min.
High-throughput sequence analysis. PCR products from 8 dpf were sequenced using a 318TM chip 
(LieTechnologiesTM) on an Ion Torrent Personal Genome Machine (LifeTechnologiesTM) at the Systems Biology 
Centre in Plymouth University (UK) as described by57. Sequences were binned by sample and filtered within 
the PGM software to remove low quality reads. Data were then exported as FastQ files. Taxonomic analyses of 
sequence reads were performed after the removal of low quality scores (Q score < 20 at 80% probability) with 
FASTX-Toolkit (Hannon Lab, USA). Sequences were concatenated and sorted by sequence similarity into a sin-
gle fasta file. Sequences were denoised and analyzed with QIIME59. Briefly, OTU mapping was performed using 
the USEARH quality filter pipeline60, to remove putatively erroneous reads (chimeras), then OTU picking was 
achieved with a minimum pairwise identity of 97%. The most abundant sequence in each OTU were selected 
to assign a taxonomic classification based on the Greengenes database61 using the RDP classifier62, clustering 
the sequences at 97% similarity with a 0.80 confidence threshold. PyNast was used to create a multiple align-
ment of the representative sequences for each OTU63 with minimum sequence length threshold of 150 bp and 
95% identification. Sequences were filtered to remove outliers, filter positions with gaps (0.95) and singletons. 
Highest homologous species were identified at 97% and minimum of 150 bp using nucleotide collection database 
at BLAST-NCBI.
Alpha diversity metrics were calculated on rarefied OTU tables with QIIME to assess sampling depth coverage 
using observed species, phylogenetic diversity, Chao1, Shannon’s diversity index and Good’s coverage. QIIME was 
also used to calculate Beta diversity metrics among samples using weighted Unifrac distances64 and Bray-Curtis 
similarity37. The distance matrixes were represented by a two dimensional principal coordinates analysis (PCoA) 
plot.
RNA extraction and cDNA synthesis. Total RNA was extracted from 15 whole larvae per tank per time 
point using an RNAeasy® minikit (Qiagen, UK) following the manufacturer’s protocol. The extracted RNA was 
eluted following2.
Real time PCR. PCRs were performed with the SYBR green method in an iQ5 iCycler thermal cycler 
(Bio-Rad laboratories). Triplicate PCRs were carried out for each sample analyzed following65.
β-actin (actβ)66 and acidic ribosomal protein (rplp)67 were used as the housekeeping genes to standardize the 
results by eliminating variation in mRNA and cDNA quantity and quality68. The reference genes were chosen 
because their mRNA levels did not vary between experimental treatments or between developmental stages. 
Modification of gene expression is reported with respect to the control sample. The primer sequences for cb1, npy, 
leptin, mc4r, glp-1, nucb2a, rplp and actβ were designed using Primer3 (210 v. 0.4.0). The primer sequences are 
reported in supplemental Table 1.
Feed intake. Zebrafish larvae were maintained in tanks at 27.0 ± 0.5 °C under a 12:12 hours light:dark pho-
toperiod. At 8 dpf, 11 zebrafish larvae per group were fed newly-hatched Artemia salina nauplii (approximately 
400 μ m) with the same concentration of A. salina (7 A. salina per μ L). A. salina were cultured daily from cysts 
(Artemia Cysts, INVE, Thailand). Zebrafish larvae were fed for 6 min with A. salina nauplii, and the food intake 
activity of each single larvae was monitored with the aid of a Stemi 2000 micrometric Microscope (Zeiss Vision 
Italia, Castiglione Orona, Italy) and A. salina intake per larvae were counted.
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Larval glucose level. Total larvae glucose levels were determined from 4 pools of 15 larvae per treatment 
at 8 dpf, using an enzymatic kit that detects D-glucose (D-Fructose and D-Glucose, Megazyme, Ireland) follow-
ing the manufacturer’s protocol. The concentration of each sample was determined with a spectrophotometer 
SHIMADZU UV-1800 (Shimadzu Scientific Instruments, USA).
The final glucose concentration was correlated to the initial pool larvae weight and finally a measurement units 
conversion from gL−1 to μ gμ L−1 and related to 1 mg of pool larvae.
Transmission Electron Microscopy (TEM). Samples of 10 zebrafish larvae at 8 dpf were fixed with 1% 
potassium dichromate, 1% osmium tetroxide and 2% glutaraldehyde in cacodylate buffer (0.1 M, pH 7.2) for 5 
hours at 4 °C. Samples were processed and stained following2. All measurements were taken from micrographs 
using Software Image J64.
BODIPY C-5 (3834) staining. Fifteen larvae per treatment at 8 dpf were placed into 12-well plastic 
dishes (3 larvae per well) and soaked in 100 μ M BODIPY C-5 (4,4-Difluoro-1,3,5,7-Tetramethyl-4-Bora-
3a,4a-Diaza-s-Indacene) (Invitrogen) diluted in 2% DMSO, then incubated for 1 hour at 28  °C in the dark. 
BODIPY C-5 specifically binds Short Chain Fatty Acids (SCFAs). Larvae were anaesthetized following2. BODIPY 
C-5 was excited at 505 nm (blue light) and emitted a spectrum of wavelength light which peaked at 515 nm. 
Regions of Interest (ROI) of 15 gallbladders and 15 intestines per group were selected. Fluorescence intensity 
(a.u.) was determined using Image J software64.
Statistical analysis. Results were expressed as the mean ± s.d. Statistical differences were determined using 
2 way ANOVA, followed by Bonferroni’s multiple comparison test. All statistical analyses were performed using 
Prism 6 (GraphPad Software, San Diego, CA, USA). A t-test was used to identify significant differences in feed 
intake, glucose levels and BODIPY fluorescence. STAMP, Venny diagram, ape and vegan packages of R were used 
to analyze the high-throughput sequencing data. P-values < 0.05 were considered significant.
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